ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)

$7.51 0.04 (0.5355%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) News Sources

Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

16-04-2026

yahoo.com

Aligos and Xiamen Amoytop sign deal for HBV therapy

17-04-2026

pharmaceutical-technology.com

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24-04-2026

yahoo.com

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026

30-04-2026

yahoo.com

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

07-05-2026

yahoo.com

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026

13-05-2026

yahoo.com

Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection

13-07-2026

yahoo.com

Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026

30-07-2026

yahoo.com

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

06-08-2026

yahoo.com

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

12-08-2026

yahoo.com

ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) Sentiment Trend

0 25 50 75 100 85 90 84 90 89 71 87 90 89 87 16-04-2026 17-04-2026 24-04-2026 30-04-2026 07-05-2026 13-05-2026 13-07-2026 30-07-2026 06-08-2026 12-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) FAQs

toggle

What is the current price of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?

The current price of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is $7.51.


toggle

ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) absolute price change since previous trading day?

The absolute price change of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) since the previous trading day is $0.04.


toggle

ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) percentage price change since previous trading day?

The percentage price change of ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) since the previous trading day is 0.5355%.


toggle

What is the most recent average sentiment score for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?

The most recent average sentiment score for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is 86 out of 100.


toggle

What is the most recent average sentiment for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)?

The most recent sentiment for ALIGOS THERAPEUTICS INC (ALGS:NASDAQ) is .


SEC-8K** Filing Available For ALIGOS THERAPEUTICS INC (ALGS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.